Tokyo’s Eisai Co Ltd, with its United States subsidiary Eisai Inc and Arena Pharmaceuticals Inc, recently announced its disclosure of the test results from the Behavioral Modification and Lorcaserin for Overweight and Obesity Management, or BLOOM, trial.
Lorcaserin is a new drug for treating weight management and obesity. Arena Pharmaceuticals Inc subsidiary Arena Pharmaceuticals GmbH provided Eisai Inc the exclusive rights to promote and sell the drug in America. According to the data presented, the drug caused subjects to lose weight better and improve weight loss management as opposed...
